Metformin Hydrochloride 125 mg/mL Oral Suspension

Metformin Hydrochloride 125 mg/mL Oral Suspension is a compounded liquid formulation designed to provide an alternative dosing option for patients requiring metformin therapy who may have difficulty swallowing traditional tablets or require precise dosing adjustments. Metformin is a biguanide class medication primarily used in the management of type 2 diabetes mellitus to improve glycemic control.

This oral suspension offers a uniform dispersion of Metformin Hydrochloride throughout the liquid medium, ensuring consistent dosing with each administration. The compounded formulation allows for flexibility in dosing, which can be particularly beneficial for pediatric patients, geriatric patients, or those with swallowing difficulties (dysphagia).

Metformin works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. It does not cause insulin release from the pancreas and does not usually cause hypoglycemia when used alone. This makes it a cornerstone in the management of type 2 diabetes mellitus, especially in overweight patients.

For prescribers, this formulation allows for individualized dosing regimens tailored to the patient's specific needs. It may also be useful in patients with gastroparesis or other gastrointestinal conditions where tablets may not be adequately dissolved or absorbed. The liquid form ensures rapid and uniform availability of the active drug.

Patients using this formulation should be aware of the potential side effects of metformin, which may include gastrointestinal disturbances such as diarrhea, nausea, vomiting, and abdominal discomfort. These side effects are often transient and may decrease over time. Starting with a lower dose and gradually increasing as tolerated may help minimize these effects.

It is important to monitor renal function before initiating therapy and periodically thereafter, as metformin is contraindicated in patients with severe renal impairment due to the risk of lactic acidosis, a rare but serious complication. Patients should also inform their healthcare provider of any history of liver disease, alcohol abuse, or other conditions that may increase the risk of lactic acidosis.

Administration of the oral suspension should be done with care to ensure accurate dosing. Patients or caregivers should use an appropriate measuring device (such as an oral syringe or dosing cup) to measure each dose accurately. Shaking the bottle well before each use ensures the medication is evenly dispersed.

As with all medications, adherence to prescribed dosing schedules is crucial for optimal therapeutic outcomes. Patients should maintain regular follow-up appointments with their healthcare provider to monitor blood glucose levels and adjust dosing as necessary.

If you have any questions or require further information about Metformin Hydrochloride 125 mg/mL Oral Suspension, please do not hesitate to reach out to us.

Metformin Hydrochloride 125 mg/mL Oral Suspension is a liquid dosage form designed to provide a homogeneous mixture for administration, ensuring consistent dosing and ease of use, particularly for patients who may have difficulty swallowing tablets. This formulation is primarily used in the management of type 2 diabetes mellitus, where it helps to control blood glucose levels by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization.

When considering the use of Metformin Hydrochloride Oral Suspension, it is crucial to be aware of potential drug interactions that may affect its efficacy or increase the risk of adverse effects. One significant interaction is with cationic drugs that are eliminated by renal tubular secretion, such as amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, and vancomycin. These drugs may compete for common renal tubular transport systems, potentially leading to increased plasma concentrations of metformin and an elevated risk of lactic acidosis.

Concomitant use of metformin with other antidiabetic medications, such as insulin or sulfonylureas, may enhance the glucose-lowering effect, increasing the risk of hypoglycemia. Patients should be monitored closely for signs of low blood sugar, and dosage adjustments may be necessary to maintain optimal glycemic control while minimizing the risk of hypoglycemia.

Alcohol consumption can potentiate the effect of metformin on lactate metabolism, increasing the risk of lactic acidosis. Patients should be advised to limit alcohol intake while using this medication. Additionally, iodinated contrast agents used in radiologic studies can lead to acute alteration of renal function, increasing the risk of metformin accumulation and lactic acidosis. It is recommended to discontinue metformin prior to or at the time of the imaging procedure and to withhold it for 48 hours after the procedure, resuming only once renal function has been re-evaluated and found to be normal.

Other medications that may interact with metformin include beta-blockers, which can mask the symptoms of hypoglycemia, and diuretics, which can affect renal function and potentially alter metformin clearance. Patients and prescribers should be vigilant in monitoring for any signs of adverse interactions and adjust treatment regimens accordingly.

For any questions or concerns regarding the use of Metformin Hydrochloride 125 mg/mL Oral Suspension and its potential interactions, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you in ensuring safe and appropriate use of this medication.

Metformin Hydrochloride 125 mg/mL Oral Suspension is a liquid dosage form designed to provide a uniform dispersion of metformin hydrochloride, an active pharmaceutical ingredient, throughout a liquid medium. This formulation ensures a homogeneous mixture, allowing for precise dosing and ease of administration, particularly beneficial for patients who may have difficulty swallowing tablets or require tailored dosing adjustments. The liquid suspension is carefully compounded to maintain stability and efficacy, ensuring that each milliliter contains an accurate concentration of the active ingredient.

Metformin is a biguanide class medication primarily used to manage type 2 diabetes mellitus. It works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and enhancing insulin sensitivity by increasing peripheral glucose uptake and utilization. This multifaceted mechanism of action helps to lower blood glucose levels, thereby improving glycemic control in patients with type 2 diabetes. By improving insulin sensitivity, metformin also aids in reducing insulin resistance, a common issue in type 2 diabetes, which can help in managing associated metabolic conditions.

The oral suspension form of metformin hydrochloride is particularly advantageous for pediatric patients, elderly patients, or those with dysphagia, as it allows for easier swallowing and the ability to adjust doses more precisely than with solid dosage forms. This flexibility can be crucial in achieving optimal therapeutic outcomes, as it enables healthcare providers to tailor the dosage to the individual needs of the patient, taking into account factors such as age, weight, renal function, and response to therapy.

For prescribers, the metformin hydrochloride oral suspension offers a versatile option for managing type 2 diabetes, especially in patients who require a non-standard dose or have specific administration challenges. It is important to monitor patients regularly to assess the effectiveness of the treatment and make any necessary adjustments to the dosage. Additionally, prescribers should educate patients on the importance of adhering to their prescribed regimen and maintaining a balanced diet and regular exercise to enhance the therapeutic effects of metformin.

Patients using this formulation should be aware of potential side effects, such as gastrointestinal disturbances, which are common with metformin therapy. These can often be minimized by starting with a lower dose and gradually increasing it as tolerated. Patients should also be informed about the signs of lactic acidosis, a rare but serious side effect, and advised to seek medical attention if they experience symptoms such as unusual muscle pain, difficulty breathing, or severe fatigue.

If you have any questions or require further information about Metformin Hydrochloride 125 mg/mL Oral Suspension, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation or its use in managing type 2 diabetes.